| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |